2011:
February 20 - March 20:
Director Geoff Bond, MS, C.Eng, MICE, MIL, MITI was again invited for a lecture tour of Southern California.
March 24:
Dr. Eytan Ellenberg, MD, PhD, MBA has joined the International Institute of Medicine and Science in Rancho Mirage, California as Vice President for Business Development.
Dr. Ellenberg earned his MD degree in Public Health and Social Medicine in October 2004 from the University of Paris-Sorbonne ("Nouvelle Sorbonne Paris III"). He also holds a PhD in Medical Linguistics from the same institution, an MBA from the Sorbonne Business School, and an Ultimate CRA Development in Pharmaceutics in 2010. Prior to that, he received a specialized Master degree in Hospital Risk Management from the Ecole Centrale de Paris in 2003 and a Master degree in Biostatistics and Modeling from the University of Paris, Faculty of Medicine Paris VII in 2003.
After several Internships in Public Health (with the French Ministry of Labor and Social Affairs with emphasis in Suicide Prevention and Psychiatry in Prisons, 2000-2001; with the European Hospital Georges Pompidou, with emphasis on Hospital Risk Management and Information Systems, 2001; with the Pediatric Hospital Robert Debre, with emphasis on Accreditation and Hospital Risk Management, 2001-2002; with the Ethical Committee of Hopitaux de Paris with emphasis on research coordination on application of French Law and Ethics and Bioethics in hospitals and Ethics in Europe, 2002-2004, Dr. Ellenberg became research coordinator and lecturer in the Faculty of Medicine, Paris-Sud, Department of Research on Ethics, 2004. He was also Medical Advisor for Arsenal/TBWA WorldHealth, 2004-2006. His charge was in Ethics (neurology, pain, ophthalmology, diabetes, cardiovascular, oncology, dermatology,etc.), Pre-launches and Launches (for Pfizer, Grunenthal, Abott, Schering-Plough, Novartis, and others), and Public Health (healthcare networks, French national insurance). He developed expertise in copyrighting, communication strategy and operational planning, strategic planning, global communication counseling, Key Opinion Leaders' relations and medical education, board organization, public relations, and international communication.
Dr. Ellenberg subsequently became Medical Director of Orkyn" (Home Care provider, and a subsidiary of Air Liquide), 2007-2010. He was responsible for quality of care (protocols, procedures, clinical follow-up of 85,000 patients for sleep apnea, respiratory failure, diabetes, Parkinson, Alzheimer) and supervised 700 home care technicians, nurses and dietitians. He was also responsible for Key Opinion Leaders' relations (in pneumonology, diabetology, neurology), patient education and disease management programs, especially in COPD), and clinical studies (interaction with sales forces, business development, marketing and innovation).
After a sabbatical as a Visiting Professor at the Universidade Federal Do Estado Do Rio de Janeiro-UNIRIO, Brazil, in Medical Linguistics, 2010, he assumed his current position since July 2010 as Medical Director of Air Liquide Sante International ALSI (home care development). He is charged to define and improve the home care positioning of ALSI, develop new indications for oxygen use in neurology and cardiology, define disease management programs, and increase market access.
Dr. Ellenberg has published extensively on clinical and hospital risk management, and bioethics and public health. He is the author of a book on the dangers posed by hospitalization.
In his position as Vice President for Business Development, Dr. Ellenberg is charged to develop this Institute's research, education and service programs on an international scale.
March 26:
The International Institute of Medicine and Science, Inc. has entered in an agreement with Words4Health to promote its development in research, specialized medical/science education and service to the communities served and to humanity.
March 28:
Kenneth Kei Adams, MD, DABPM&R is elected Director/Trustee of the International Institute of Medicine and Science in Rancho Mirage, California.
Dr. Adams received his medical education from the University of Texas Southwestern Medical School at Dallas from which he received his MD degree (specialization: Physical Medicine & Rehabilitation - PM&R) in May 1997. He is a Diplomate of the American Board of Physical Medicine & Rehabilitation.
Dr. Adams held several executive positions including: CEO & Medical Director of Vertical Assurance, LLC (2003-2007); CEO & Medical Director of Inpatient Rehabilitation Specialists (since August 2001); Medical Director of PrimeCare Home Health Care (2001-2007); Medical Director of CardioDiagnostic Group (2001-2008); Medical Director of the Inpatient Rehabilitation Unit at the Medical Center of Plano (2003-2005) and at RHD Memorial Hospital (2001-2006); Corporate Medical Director (2005-2006), Chief Medical Officer and Senior Vice President of Medical Affairs (2005-2008) of RehabCare Group; and CEO of Skilled Rehab Specialists (since 2008).
Dr. Adams is a Member of several professional associations: American Academy of Physical Medicine & Rehabilitation (AAPM&R), Health Policy and Legislative Committee (2008) and the only physician on its Technical Expert Panel to Interpret CMS 75/25 rule (2004); National Medical Advisory Board for RehabCare (member since 2004 and chairman in 2005-2008); American Medical Rehabilitation Providers Association (AMRPA), National Clinical Advisory Group (member since 2004, chairman since 2006).
Dr. Adams was Assistant Instructor (2000-2001), Assistant Clinical Professor (2001-2009), Associate Clinical Professor (2010-) of Physical Medicine & Rehabilitation at the University of Texas Southwestern Medical School at Dallas. He was also Chief of Staff at the RHD Memorial Medical Center (2005-2006); Member of the Board of Directors and Treasurer (2003-2007) and Director of Board Expansion of Metrocrest Hospital Foundation (2003-2005); and a member of the Board of Directors of the American Medical Rehabilitation Providers Association (2007-2011).
Dr. Adams has received several honors and awards including "Best Doctors in Dallas" from the D-Magazine (2003 and 2004); "National Medical Director of the Year" from RehabCare (2002); and "Young Physician Award" from the American Medical Association (2003). He has lectured extensively across Texas, and published the first on-line Physiatry textbook. He is a sports team physician and a global volunteer medical staff in countries such as Haiti, China, Venezuela, Belgium, and Cuba.
Dr. Adams will advise the Board at large on all matters relating to physical medicine and rehabilitation including strategic planning and growth, legislative involvement in health care, media relations, and regulatory compliance.
March 29:
Amir H. Karimzadeh, PharmD, N.Ph. is elected Director/Trustee of the International Institute of Medicine and Science in Rancho Mirage, California.
Dr. Karimzadeh received his Pharmacy degree from the University of Washington, Seattle, Washington, and his degree in Nuclear Pharmacy from the University of Arkansas. He then joined the Good Samaritan Hospital and Medical Center as a Clinical Pharmacist for infectious diseases, nephrology, oncology, cardiology, general medicine and nutritional support teams, 1987-2001. For the period 1999-2000, he also served concurrently as a Clinical Nuclear Pharmacist with Syncor International Corporation. Subsequently, he was appointed Associate Director and Clinical Specialist at Tuality Healthcare, Hillsboro, Oregon, 2000-2002, and Clinical Psychiatric Pharmacist at Tuality Forest Grove Hospital, Forest Grove, Oregon, 2002-2004. He subsequently joined the Forest Research Institute as a Senior Medical Liaison in the Central Nervous System Division, 2002-2005. Thereafter he was appointed Senior Manager at the Allergan Neurosciences Division of Genitourinary Health, Irvine, California, 2005-2006. He then moved to Elan Pharmaceuticals as a Regional Medical Director for Immunotherapy, South San Francisco, 2006-2009. He is currently, and since 2009, Vice President for Medical Affairs and Medical Director at Cory/Paeth Medical Education Group, Chicago, Illinois.
Dr. Karimzadeh is a member of several professional associations, including the American Academy of Medical Directors, the American College of Clinical Pharmacists, and the American Society of Healthcare Pharmacists. He has been active in research and education with several publications and presentations.
Dr. Karimzadeh will advise the Board at large on all matters relating to clinical and nuclear pharmacology including novel methodologies in research and education in these fields.
March 30:
Robert D. Solomon, MD, DABR joined the International Institute of Medicine and Science in Rancho Mirage, California.
Dr. Solomon completed his medical studies at the Boston University School of Medicine, Boston, Massachusetts, in 1988 with honor courses in Pathology, Biology of Disease, Neurology, and Pediatric Radiology. After an Internship at the Monmouth Medical Center, Long Branch, New Jersey, in Internal Medicine in 1989, he completed his Residency in Diagnostic Radiology at the State University of New York Health Sciences Center, Brooklyn, New York, in 1993. He then became Staff Radiologist at the North Shore University Hospital at Glenn Cove, New York, 1993-1994, at the Long Island Diagnostic Imaging, New York, 1994-1995, and at the Parkway MRI, P.C., Brooklyn, New York, 1995-1999. He became Medical Director and Staff Radiologist at Complete Radiology, P.C., Brooklyn, New York, 1998-present and also at the Richmond Radiology, P.C., Brooklyn, New York, since 2001.
Dr. Solomon is a Diplomate of the National Board of Medical Examiners and the American Board of Radiology. He is a member of several professional associations including the Radiological Society of North America and the American College of Radiology. He specializes in most areas of diagnostic radiology (neurology, CT/US/MRI, angiography/interventional, pediatric, mammography, bone densitometry). His two chief interests are in transcranial magnetic stimulation and its improvement of functional MRI, and in medical imaging in drug development trials. His other interests include Telemedicine/Teleradiology.
Dr. Solomon will advise the Board on all matters relating to all modalities of diagnostic radiology as well as new technological developments in these areas.
March 31:
Dr. Chittarvu Venkatesh, DDS joined the International Institute of Medicine and Science in Rancho Mirage, Caifornia.
April 2:
Dr. Khartik Anantharaman, MBA, MBBS joined the International Institute of Medicine and Science in Rancho Mirage, California.
April 4:
Dr. Anil V. Arundi, DDS joined the International Institute of Medicine and Science in Rancho Mirage, California.
April 5:
Director Dr. Alain L. Fymat, BA, BS, MA, MS, PhD, PhD has accepted an invitation from Akademia Kiado (the Hungarian Academy of Medicine and Science, founded in 1828) and Semmelweis University to join the Board of Reviewers of its Interventional Medicine and Applied Sciences Journal. The Journal is hosted by four scientific societies:
The focus of the Journal is to dynamically improve interventional activities in all fields of medicine, including minimally invasive specialties: cardiology, angiology, laparoscopy surgery, invasive radiology, anesthesia and intensive care medicine, as well as all fields of applied sciences. Dr. Fymat will review original submissions in Radiology, Radiological Sciences, Radiation Oncology, Critical Care Medicine, and Physics.
May 10:
Within his institution, Euromedicodentale, SA, Director Dr. Gerard Sabbah, DDS inaugurated his Center for Facial Surgery and Medicine ("Centro di Chirurgia e Medicina del Viso") including implantology, esthetic medicine, and TAC. Dr. Sabbah is now its Chief Executive Officer. Together with his associate, Dr. Claude Schiff, DDS, Dr. Sabbah also inaugurated a Division of Radiology within Euromedicodentale.
May 15:
Dr. Jean-Philippe Azulay, MD, PhD is elected Director/Trustee of the International Institute of Medicine and Science in Rancho Mirage, California.
Dr. Azulay completed his medical studies and obtained his Physician License from the University of Aix-Marseille II, France, in 1990. That same year, he also obtained his Certification in Neurology by the French Board of Neurology and became a member of the French Board of Physicians. Subsequently, in 1998, he received a PhD in Neurosciences from the same University. Since 1990, Dr. Azulay has been Attending Physician at the University Hospital de la Timone, Marseille, France. In 1999, he became Professor of Neurology at the School of Medicine of Marseille and, since 2007, the Head of its Movement Disorders Unit.
Dr. Azulay is also a Research Scientist with the French National Center for Scientific Research and a Member of the team on Movement Disorders and Developmental Aspects. In these activities, he is often called on to review articles submitted for publication in numerous professional journals, including: Brain, Neurology, Journal of Neurology, Neurology and Psychiatry, Experimental Brain Research, Clinical Neurophysiology, Journal of Neurological Sciences , Revue Neurologique, and Neuroscience Letter. He is also an expert and key opinion leader for drug companies, includingAFSSAPS and ANR. Dr. Azulay is a member of several scientific societies, including: French Neurological Society, French Neurophysiological Society, Movement Disorders Society, and is on the Editorial Board of La Revue Neurologique. He has published over 140 articles and book chapters in the field of neurology and neurological science.
Dr. Azulay has extensive experience in clinical trials having participated or conducted more than 50 such trials with main fields in Parkinson's disease, ALS, atypical parkinsonian syndromes.
In his role as Director/Trustee, Dr. Azulay will advise the Board at large on all matters relating to neurology and neurological science with particular emphasis on movement disorders.
May 21:
Director, Dr. Alain L. Fymat, BA, BS, MA,. MS, PhD, PhD was invited and accepted the added position of Visiting Consultant at the Interventional Cardiac Centers of India and at the Advanced Center for Cardiovascular Disease and Research, Rockford Hospital, New Delhi, India. In this position, Dr. Fymat will advise the executive management of these Centers on most appropriate ways of implementing and expanding a network of interventional cardiovascular centers within established hospitals across India.
May 24:
Dr. Narendra Vikramaditya Yadav, MD, MRCP(UK) is elected Director/Trustee of the International Institute of Medicine and Science in Rancho Mirage, California.
Dr. Vikramaditya completed his medical education in 1999 with an MD degree from the Calcutta National Medical College, Calcutta University, one of the oldest and most prestigious medical colleges of India including an 800-bed hospital. He completed Fellowships in Interventional Cardiology (2004), Laser Interventions (2005), Complex Angioplasty (2008) and Remote Magnetic Navigation Systems (2010). He subsequently completed his MRCP (Member, Royal College of Physicians) from St Georges Hospital, London (UK) in 2001. After extensive training in interventional cardiology, he was awarded membership in the British Cardiac Society. In 2002, he joined St. Georges Hospital as an interventional cardiologist. He became Editor and Reviewer of the British Medical Journal. Dr. Vikramaditya also became an International Associate of the American College of Cardiology in 2003. That same year, he joined Escorts Heart Institute in New Delhi, became a Fellow in Complex Angioplasty, Laser Angioplasty, and Rotacs Procedure from Rosalind Franklin University of Medicine and Science, Chicago.
Dr. Vikramaditya returned to India in 2006 and joined the Wockhardt Heart center, Hyderabad, as a Consultant Interventional Cardiologist. He also became reviewer for the International Journal of Cardiology.
Dr. Vikramaditya specializes in conventional angiography and angioplasty, complex coronary interventions, peripheral interventions, pacemaker implantation, ICD implantation, laser intervention device, USG PTCA device, rotablation, rotational atherectomy device, directional atherectomy device, rotacs procedures, intravascular ultrasound, and remote magnetic navigation system. In 2006, he joined the Apollo Group of Central India.
In 2009, Dr. Vikramaditya became Director for Cardiac Sciences at the Cardiac Centre, Ivy Hospital at Mohali and subsequently joined the Fortis Group as Director of its Cardiovasclar Division. In the last 5 years, Dr. Vikramaditya has performed in excess of 1,000 complex angioplasties including left main, TVDs, bifurcations, CTOs and primary angioplasties. Dr. Vikramaditya is associated with Klinikum Nurenberg Hospital, Nurenberg, Germany as a Senior Interventional Cardiologist. In addition, he is also a Visiting Consultant to University Teaching Hospital, Spain, Glasgow Hospital in Scotland, Al Hilal Hospital in Bahrain, and the National Heart Institute, East of Kailash, New Delhi. Dr. Vikramaditya received a number of awards including the Young Cardiologist Award by the Government of Spain (2003) and the Outstanding Service to people Award by the U.S. Government (2005).
In his new role as Director/Trustee, Dr. Vikramaditya will advise the Board at large on new developments in interventional cardiology and will expand the role of the Institute in this important area.
June 5:
Dr. Bogdan Nicolescu-Catargi, MD, PhD is elected Director/trustee of the International Institute of Medicine and Science, Inc. in Rancho Mirage, California.
Dr. Catargi received his medical degrees from the University Hospital of Bordeaux, France. He is currently a Professor of Medicine in the Department of Endocrinology of that University and a Vice-President of the EVADIAC study group.
Dr. Catargi is involved in clinical research with continuous glucose monitoring and insulin pumps (external and implantable). He has published numerous articles on this subject in the professional literature (Journal of Control Release, Journal of Colloidal Interface Science, Diabetes Metabolism, and Expert Review of Medical Devices). He also holds the French patent (dated January 13, 2010) on a clinical insulin detector including its process of fabrication.
Dr. Catargi is also a consultant to the medical device industry for continuous glucose monitoring devices and insulin pumps (Medtronic, Menarini, Abbott).
In his new role as Director/Trustee, Dr. Catargi will advise the Board at large on new developments in endocrinology and will expand the role of the Institute in this important area.
June 7:
Dr. Sukesh Trikha (Surg Lt Cdr), MD is elected Director/Trustee of the International Institute of Medicine and Science in Rancho Mirage, California.
August 31:
Institute Director, Dr. Gerard Sabbah, DDS and his team (Prof.-Dr. Giuseppe Monetti, MD (musculoskeletal radiologist); Dr. Claude Schiff, DDS; Mrs. Josiane Sabbah, Executive Director) of G3D, a subsidiary of Euro-Medicale, Ltd.) visited PLANMECA in Helsinki, Finland. PLANMECA is the manufacturer of advanced imaging dentistry equipment, including the state-of-the-art Cone Beam Computed Tomography (CBCT) system. PLANMECA was represented by its President/CEO and its Vice President for international relations.
The G3D team proposed a cooperative project aimed at the utilization and global expansion of cone-beam radiological imaging of the complete face for dental implantology, maxillo-facial surgery, facial esthetic & reconstructive surgery, and musculo-skeletal radiology & corrective surgery. A test pilot for the project consists in the development of a mobile radiological unit including a beta version of the Planmeca Promax 3D Pro-face system, a magnetic resonance imaging (MRI) unit, and an ultrasound echo imaging unit.
According to its manufacturer,"the Planmeca Promax 3D Pro-face system is a unique CBCT imaging unit with integrated three-dimensional patient's face scan system that is acquired in a radiation-free process. This true three-dimensional application is designed to fulfill the most diverse diagnostic needs of today's maxillo-facial and dental professionals. It affords the medical or dental professional the opportunity to plan interventions and document the follow-up images. It also enables safer and faster facial surgeries". By augmenting this system with a magnetic resonance imaging unit and an ultrasound echo Doppler unit, the G3D team will additionally be able to provide the optimal diagnosis for osteo-articular pathologies.
Advantages of this project include: (1) Patients are no longer required to visit the diagnostic/treatment centers, the reverse actually takes place; (2) The combined use of the three technologies reinforces diagnostic quality and allows the surgeon to optimize his/her intervention; (3) the radiological report represents the GPS for the surgery, which would enable optimal surgery and post-surgery follow-ups.
The project is jointly sponsored by G3D, the University of Bologna (Italy), School of Musculo-Skeletal Radiology (Director: Professor Giuseppe Monetti, a world leader in static and dynamic radiology) and the International Institute of medicine and Science, Inc..
October 3:
Dr. Boris Herscovici (Herskowitz), PhD has been appointed International Correspondent of the International Institute of Medicine and Science in Rancho Mirage, California.
Dr. Herscovici completed his education at theUniversity "Dunarea de Jos", Galati, Romania, initially in the Institute of Food Science and Technology (MSc, Food Engineering, 1977) and subsequently in the Department of Biochemistry, Galati (PhD, Industrial Engineering, 2006). His field of scientific expertise is in food technology and medical nutrition. He has lectured extensively across Europe (Switzerland, Romania, Germany, Italy, Holland, Belgium, United Kingdom, France, Denmark), Minor Asia (Turkey, Israel), and the U.S.
Dr. Herscovici is the co-author of several scientific publications, a book and a patent. He is also a member of several national and international professional societies.
Dr. Herscovici is currently employed by the Technion R&D Foundation Ltd, Liaison Office, National, Bi-Lateral and EUREKA Programs, Haifa, israel.
As a corresponding member, Dr. Herscovici will update the Institute's Board on issues concernant nutritional medicine, lifestyle modifications and age extension. He will also be a catalyst in the initiation and implementation of joint research, education and service projects between the Institute and the Technion R&D Foundation.